Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
University of Bristol researchers have discovered a VEGF-C gene therapy that protects the kidneys and may prevent serious complications in people with type 1 diabetes.
Public Health England, Faculty of Sport and Exercise Medicine and Sport England have joined forces to release a new physical activity resource for professionals in the healthcare sector.
Sarah Bateup, Chief Clinical Officer at Ieso Digital Health, introduces the first in a two-part series of articles demonstrating how combining mental health treatments with physical treatments can have a positive effect on the overall wellbeing and outcomes for patients
SocialDiabetes is participating in two NHS testbed projects to pilot the future of digital health and patient-centric diabetes care, as Ikuska Sanz, the firm’s Director of Operations describes
Chris Askew, Chief Executive at Diabetes UK argues that more needs to be done to support the one in six people in hospital that have diabetes, who currently experience unnecessary harms that can lead to long lasting harm or death.
Public Health England have released a report which shows those suffering with severe mental illnesses experience worse physical health compared to the general population.
Simon Gillespie, Chief Executive of the British Heart Foundation ponders if escalating diabetes rates could reverse success in reducing heart disease deaths
Professor Nam H. Cho, President of the International Diabetes Federation (IDF) explains why governments across the world could and should do more to help people with diabetes and their families.
Asthma UK’s recent report explores the barriers to life-changing treatment for people with uncontrolled asthma, as Joe Farrington-Douglas, Head of Policy and External Affairs at Asthma UK explains.
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH shares his views on data-based solutions for diabetes.
Paulus Carpelan, Vice President at Quattro Folia Oy argues that now is the time to rethink healthcare when it comes to the treatment of people with diabetes.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group shares her thoughts on mobile health monitoring systems that address the global concern of diabetes
